Takeda Pharmaceutical (TAK) Return on Capital Employed [ROCE] (2019 - 2026)
Takeda Pharmaceutical's Return on Capital Employed [ROCE] came in at 3.34% for the quarter ended Jun 30, 2026, down 2.65 percentage points from 5.98% a year earlier and down 0.01 percentage points from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends
For the year ended Mar 31, 2026, Takeda Pharmaceutical's Return on Capital Employed [ROCE] was 0.05%, down 2.67 percentage points from the prior year.
- Return on Capital Employed [ROCE] carries a five-year change of -4.61 percentage points (years ended Mar 2021 to Mar 2026).
- Going back by year, Return on Capital Employed [ROCE] was 2.72% in the year ended Mar 31, 2025 (+1.03 pp), 1.69% in the year ended Mar 31, 2024 (-2.26 pp), 3.95% in the year ended Mar 31, 2023 (-0.14 pp) and 4.09% in the year ended Mar 31, 2022 (-0.57 pp).
- The five-year range for quarterly Return on Capital Employed [ROCE] is 3.22% (the quarter ended Dec 31, 2025) to 8.46% (the quarter ended Mar 31, 2022).
- Year-over-year, Return on Capital Employed [ROCE] has declined for eight consecutive quarters, with an average year-over-year change of -1.45 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in the quarter ended Mar 31, 2024 (a gain of 1.71 percentage points), and the weakest in the quarter ended Jun 30, 2023 (a drop of 3.54 percentage points).
- Business Quant data shows TAK's Return on Capital Employed [ROCE] at 3.34% (quarter ended Mar 31, 2026), 3.22% (quarter ended Dec 31, 2025) and 5.86% (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Takeda Pharmaceutical | 2.58 Bn | -23.92 Bn | 5.10 Bn | 3.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.34% |
| Mar 31, 2026 | 3.34% |
| Dec 31, 2025 | 3.22% |
| Sep 30, 2025 | 5.86% |
| Jun 30, 2025 | 5.98% |
| Mar 31, 2025 | 5.73% |
| Dec 31, 2024 | 5.33% |
| Sep 30, 2024 | 6.60% |
| Jun 30, 2024 | 6.40% |
| Mar 31, 2024 | 6.89% |
| Dec 31, 2023 | 6.99% |
| Sep 30, 2023 | 7.10% |
| Jun 30, 2023 | 4.86% |
| Mar 31, 2023 | 5.18% |
| Dec 31, 2022 | 6.02% |
| Sep 30, 2022 | 7.04% |
| Jun 30, 2022 | 8.40% |
| Mar 31, 2022 | 8.46% |
| Jun 30, 2021 | 7.31% |
| Mar 31, 2021 | 7.64% |
API Access
Takeda Pharmaceutical Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();